Annual Drug Patent Expirations for TYMLOS
Tymlos is a drug marketed by Radius Health Inc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
This drug has forty-three patent family members in twenty-six countries.
The generic ingredient in TYMLOS is abaloparatide. One supplier is listed for this compound. Additional details are available on the abaloparatide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
You must log in to post a comment.